P1.168. Lymph Node Metastatic Patterns and Therapeutic Value Index in Esophagogastric Junction Cancer: Esophageal Invasion Length and Neoadjuvant Chemotherapy

Clicks: 17
ID: 326031
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #356 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer Background The surgical approach and extent of lymph node (LN) dissection for esophagogastric junction (EGJ) carcinoma are stratified by the length of esophageal invasion (EIS); however, inter-institutional variation remains. We investigated LN metastasis patterns, the therapeutic value index (TI), and the impact of neoadjuvant chemotherapy (NAC) to optimize mediastinal LN dissection at our institution. Methods We retrospectively reviewed 111 patients with EGJ carcinoma (adenocarcinoma or squamous cell carcinoma) diagnosed by the Nishi classification who underwent R0/R1 resection between 2010 and 2025. Clinicopathological characteristics and postoperative outcomes were assessed. LN metastasis (LN+) rates and TI were compared by EIS: group A (≤1 cm; n=48), group B (1–3 cm; n=42), and group C (>3 cm; n=21). Among adenocarcinoma patients receiving NAC (n=15), therapeutic effects were categorized as grade 1 (1a+1b) (n=10) versus grade 2-3 (n=5) based on the classification of Japan Esophageal Society (JES). Results Median age was 69 years, and the male-to-female ratio was 91/20. Histology was adenocarcinoma/squamous cell carcinoma in 95/16 patients, and the overall 3-year survival rate was 78%. Pathological stage 0/I/II/III/IV was observed in 1/49/21/31/9 patients. LN stations with a metastatic rate of ≥10% were 106recR, 106recL, 107, 1, 2, 3, 7, 11p, and 19. Upper/middle/lower mediastinal LN+ rates were 0/0/3.4% in group A, 30.8/0/2.7% in group B, and 30.0/20.0/28.6% in group C. Corresponding TI were 0/0/3.4, 23.1/0/2.7, and 15.9/0/17.2, respectively. Among NAC-treated adenocarcinoma patients, upper/middle mediastinal LN+ rate/TI was 42.9% (3/7)/16.7 in the JES Grade 1 group and 0% (0/3)/0 in the JES Grade 2-3 group. In addition, upper/middle mediastinal LN recurrence occurred in 22.2% (2/9) of the JES Grade 1 group and 0% (0/3) of the JES Grade 2-3 group. Conclusion From the standpoint of LN+ rate and TI, upper/middle mediastinal LN dissection may be unnecessary for EIS ≤1 cm but warranted for EIS >3 cm. For EIS 1–3 cm, upper/middle mediastinal dissection may be considered in high-risk disease (cLN+ and/or cT2-4). Omission of upper/middle mediastinal dissection may be an option in patients who respond to NAC. Further accumulation and refinement of indications—including response-based refinement of the extent of lymph node dissection —are needed.
Reference Key
openalex_W7204000551 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Koki Fujiwara, Satoru Matsuda, K Takebe, Yosuke Morimoto, Kazuaki Matsui, Masashi Takeuchi, Hirofumi Kawakubo, Yuko Kitagawa
Are you one of these authors? Claim your profile
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.316
URL
https://doi.org/10.1093/dote/doag077.316
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.